| 持有 济川药业(600566)的基金 |
| 报告期：2023-03-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 501202 | 华泰紫金科创3年封闭混合C | 42,717,009.60 | 1,499,895.00 | 4.18 |
| 2 | 009663 | 华泰紫金科创3年封闭混合A | 42,717,009.60 | 1,499,895.00 | 4.18 |
| 3 | 000780 | 鹏华医疗保健股票 | 40,604,249.28 | 1,425,711.00 | 5.55 |
| 4 | 001917 | 招商量化精选股票A | 35,463,296.00 | 1,245,200.00 | 1.09 |
| 5 | 007950 | 招商量化精选股票C | 35,463,296.00 | 1,245,200.00 | 1.09 |
| 6 | 009300 | 西部利得中证500指数增强(LOF)C | 34,503,520.00 | 1,211,500.00 | 1.42 |
| 7 | 502000 | 西部利得中证500指数增强(LOF)A | 34,503,520.00 | 1,211,500.00 | 1.42 |
| 8 | 360005 | 光大保德信红利混合 | 14,467,840.00 | 508,000.00 | 3.59 |
| 9 | 002601 | 中银证券价值精选灵活配置混合 | 12,876,434.56 | 452,122.00 | 3.86 |
| 10 | 010268 | 太平睿安混合A | 7,102,912.00 | 249,400.00 | 1.88 |
| 11 | 010269 | 太平睿安混合C | 7,102,912.00 | 249,400.00 | 1.88 |
| 12 | 460009 | 华泰柏瑞量化先行混合A | 4,505,536.00 | 158,200.00 | 0.84 |
| 13 | 010246 | 华泰柏瑞量化先行混合C | 4,505,536.00 | 158,200.00 | 0.84 |
| 14 | 000030 | 长城核心优选混合 | 2,469,216.00 | 86,700.00 | 1.66 |
| 15 | 003876 | 华宝沪深300增强A | 2,429,344.00 | 85,300.00 | 0.48 |
| 16 | 007404 | 华宝沪深300增强C | 2,429,344.00 | 85,300.00 | 0.48 |
| 17 | 001897 | 九泰久盛量化先锋混合A | 1,848,352.00 | 64,900.00 | 3.93 |
| 18 | 004510 | 九泰久盛量化先锋混合C | 1,848,352.00 | 64,900.00 | 3.93 |
| 19 | 007283 | 华夏鼎淳债券C | 1,275,904.00 | 44,800.00 | 0.60 |
| 20 | 007282 | 华夏鼎淳债券A | 1,275,904.00 | 44,800.00 | 0.60 |
| 21 | 005225 | 广发量化多因子混合 | 495,552.00 | 17,400.00 | 1.96 |
| 22 | 410009 | 华富量子生命力混合 | 487,008.00 | 17,100.00 | 4.63 |
| 23 | 710301 | 富安达增强收益债券A | 187,968.00 | 6,600.00 | 0.36 |
| 24 | 710302 | 富安达增强收益债券C | 187,968.00 | 6,600.00 | 0.36 |
| 25 | 006231 | 国融融君混合A | 139,552.00 | 4,900.00 | 2.16 |
| 26 | 006232 | 国融融君混合C | 139,552.00 | 4,900.00 | 2.16 |
| 27 | 166108 | 信达澳银量化多因子混合(LOF)C | 116,768.00 | 4,100.00 | 0.81 |
| 28 | 166107 | 信达澳银量化多因子混合(LOF)A | 116,768.00 | 4,100.00 | 0.81 |
